ICC/IF analysis of ES cells using GTX10306 Mu Opioid receptor splice variant antibody. D3 ES cells were maintained in serum/LIF/ME induced self-renewal conditions (undifferentiated cells, D3). Upon treatment with 1 microM RA they undergo differentiation (dD3). Dilution : 1:2500
ICC/IF analysis of ES cells using GTX10306 Mu Opioid receptor splice variant antibody. D3 ES cells were maintained in serum/LIF/ME induced self-renewal conditions (undifferentiated cells, D3). Upon treatment with 1 microM RA they undergo differentiation (dD3). Dilution : 1:2500
Mu Opioid receptor splice variant antibody
GTX10306
ApplicationsImmunoFluorescence, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityMouse, Rat
TargetOPRM1
Overview
- SupplierGeneTex
- Product NameMu Opioid receptor splice variant antibody
- Delivery Days Customer9
- ApplicationsImmunoFluorescence, ImmunoCytoChemistry, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID4988
- Target nameOPRM1
- Target descriptionopioid receptor mu 1
- Target synonymsLMOR; MOP; MOR; MOR1; M-OR-1; mu opiate receptor; mu opioid receptor hMOR-1a; mu-type opioid receptor; OPRM
- HostRabbit
- IsotypeIgG
- Scientific DescriptionThe powerful effects of opiate are mediated through the opioid receptors located on the plasma membrane of neurons and other peripheral cells. There are at least 3 types of opioid receptors, mu, kappa, and delta, each with a distinct pharmacologic profile. The mu opioid receptor is the primary site of action for the most commonly used opioids, including morphine, heroin, fentanyl, and methadone.
- ReactivityMouse, Rat
- Storage Instruction2°C to 8°C,-20°C or -80°C
- UNSPSC12352203